Evidence map›Paper›PMID 31827278›Full record

ArticleNature2019

Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.

Craig Ramirez, Andrew D Hauser, Emily A Vucic, Dafna Bar-Sagi

Open access · greenAbstract read
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [ATPase HZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Ubiquitination-Driven Reprogramming of Proteostasis in Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. Article
  14. Article
  15. Cytoskeleton governs exosome-mediated drug resistance under mechanical stress.Extracellular vesicles and circulating nucleic acids · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Craig RamirezDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Andrew D HauserDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Emily A VucicDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Dafna Bar-SagiDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA. dafna.bar-sagi@nyulangone.org.
New York University · US

Funding

TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
TGFB-Dependent Mechanoresponses by Aortic Smooth Muscle Cells Govern AneurysmsP01HL134605 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUMPHREY, JAY D. · 2018 to 2022
$12.1M
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptationR35CA210263 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAR-SAGI, DAFNA · 2016 to 2022
$6.6M
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINSR37CA055360 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAR-SAGI, DAFNA · 2001 to 2008
$3.4M
GRADUATE PROGRAM IN CELLULAR &MOLECULAR BIOLOGYT32GM007238 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RIFKIN, DANIEL B · 1985 to 2013
$2.7M
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINSR01CA055360 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAR-SAGI, DAFNA · 1991 to 2015
$2.6M
Mechanisms of Signal Transduction by Ras ProteinsR56CA055360 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAR-SAGI, DAFNA · 2009 to 2009
$484k
NCI NIH HHS CA055360NCI NIH HHS CA210263NCI NIH HHS R01 CA055360NCI NIH HHS R35 CA210263NCI NIH HHS R37 CA055360NCI NIH HHS R56 CA055360NCI NIH HHS T32 CA009161NHLBI NIH HHS P01 HL134605NIGMS NIH HHS T32 GM007238NIH HHS 5 T32 GM007238
6 · The paper itself

Abstract

Oncogenic activation of RAS is associated with the acquisition of a unique set of metabolic dependencies that contribute to tumour cell fitness. Cells that express oncogenic RAS are able to internalize and degrade extracellular protein via a fluid-phase uptake mechanism termed macropinocytosis

Indexed as

PinocytosisAnimalsBicarbonatesCarcinogenesisCell Line, TumorCell MembraneCholesterolCyclic AMP-Dependent Protein KinasesFemaleHumansMiceMice, NudeNeoplasmsOncogene Protein p21(ras)Signal TransductionSodium-Bicarbonate SymportersBicarbonatesCholesterolCyclic AMP-Dependent Protein KinasesOncogene Protein p21(ras)SLC4A7 protein, humanSodium-Bicarbonate SymportersVacuolar Proton-Translocating ATPases

Identifiers

PMID31827278
PMCPMC7048194
OpenAlexW2995084623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.